News on microarrays, multiplexing, genotyping, cytogenetics, gene expression profiling in genetics, genomics, and molecular diagnostics.
The in vitro diagnostic company said it would use the financing to commercialize its antibiotic susceptibility platform called Reveal.
The firm moved closer to commercializing its lung transplant test, and it was notified by New York State that it could begin testing patient samples using its DTC celiac disease test.
Quotient said that the revenue increase was driven by higher direct product sales, as well as sales to original equipment manufacturing customers.
The company also received a contract from the Henry M. Jackson Foundation for a separate sepsis test.
Nationwide Labs will use the PathogenDx array system for rapid strain identification of skin and foot fungi.